|Articles|February 4, 2015
Astellas Broadens Commitment to Clinical Trial Data Transparency
Astellas Pharma Inc. (Tokyo: 4503, "Astellas") announced today that the company will now make trial data available through www.clinicalstudydatarequest.com,
Advertisement
Astellas Pharma announced that the company will now make trial data available through www.clinicalstudydatarequest.com , an independent Web site that enables researchers to request and access clinical trial data after approval of a research proposal by an independent review panel. This site was developed to enable researchers to request data from clinical studies and perform further research that could help advance medical science or improve patient care. In addition, Astellas also recently revised and expanded its Global Policy on Clinical Trial Data Disclosure, which details the company's principles regarding registration of clinical trials, posting and publication of trial results and scientific community access to trial data. The policy is available at www.astellas.com/en/corporate/disclosure/clinicalstudies.html .
Read the full release here.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025
Advertisement
Advertisement